Carcinoid tumors of the gastrointestinal tract: A review and the Duke University institutional overview

Minerva Chirurgica

Volumn 58, Issue 1, 2003, Pages 1-8

  Onaitis, M ^a   White, R ^a   Tyler, D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Carcinoid tumor, diagnosis; Carcinoid tumor, surgery; Gastrointestinal neoplasms

Indexed keywords

CARCINOID; DECARBOXYLATION; GASTROINTESTINAL TRACT; GASTROINTESTINAL TUMOR; HUMAN; METASTASIS; NEOPLASM; PRECURSOR; REVIEW; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS; CARCINOID TUMOR; EMBOLIZATION, THERAPEUTIC; GASTROINTESTINAL NEOPLASMS; HUMANS; INCIDENCE; INTERFERON-ALPHA; LIVER NEOPLASMS; OCTREOTIDE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0038274025     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Obendorfer S. Karzinoide tumoren des Dunndarms. Frankfurt Zeitschr Pathol 1907;1:426-32.
2. Masson P. Cacinoids (argentaffin-cell tumors) and nerve hyperplasia of appendicular mucosa. Am J Pathol 1928;4:181-212.
3. Lembech F. 5-hydroxytryptamine in carcinoid tumor. Nature 1953;172:910-1.
4. Page IH, Corcoran AC, Vollenfrend S. Argentaffinoma as an endocrine tumor. Lancet 1955;1:198-9.
5. Creutzfeld W. Carcinoid tumors: development of our knowledge. World J Surg 1996;20:126-31.
6. Kloppel G, Heitz PU. Classification of normal and neoplastic neuroendocrine cells. Ann N Y Acad Sci 1994;733:18-24.
7. Wilander E, Sceibenpflug L, Ericksson B, Oberg K. Diagnostic criteria of classical carcinoids. Acta Oncol 1991;30:469-76.
8. Eriksson B, Oberg K. Peptide hormones as tumor markers in neuroendocrine gastrointestinal tumors. Acta Oncol 1991;30:477-85.
9. Wilander E. Diagnostic pathology of gastrointestinal and pancreatic neuroendocrine tumors. Acta Oncol 1989;28:363-9.
10. Williams E, Sandler M. The classification of carcinoid tumors. Lancet 1963;1:238-9.
11. Buchanan KD, Johnston CF, O'Hare MM, Ardill JE, Shaw C, Collins JS et al. Neuroendocrine tumors. A European view. Am J Surg 1986;81:14-22.
12. Modlin I, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79:813-29.
13. Godwin J. Carcinoid tumors: an analysis of 2837 cases. Cancer 1975;36:560-9.
14. Berge T, Linell F. Carcinoid tumors. Frequency in a defined population during a 12 year period. Acta Pathol Microbiol Scand 1976;84:322-30.
15. Moertel C. An odyssey in the land of small tumors. J Clin Oncol 1987;5:1503-22.
16. Onaitis MW, Kirshbom PM, Hayward TZ, Quayle FJ, Feldman JM, Seigler HS et al. Gastrointestinal carcinoids: a characterization by site of origin and hormone production. Ann Surg 2000;232:542-56.
17. Moertel C, Saver W, Dockerty M. Life history of the carcinoid tumor of the small intestine. Cancer 1961;14: 901-12.
18. Eller R, Frazee R, Roberts J. Gastrointestinal carcinoid tumors. Am Surg 1991;57:434-7.
19. Thompson GB, van Heerden JA, Martin JK, Schutt AJ, Ilstrup DM, Carney JA. Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery 1985;98:1054-63.
20. Rothmund M, Kisker O. Surgical treatment of carcinoid tumors of the small bowel, appendix, colon, and rectum. Digestion 1994;55 Suppl 3:86-91.
21. Jetmore AB, Ray JE, Gathright JB, McMullen KM, Hicks TC, Timmcke AE. Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon Rectum 1992;35:717-25.
22. Caldarola VT, Jackman RJ, C.G. M, Dockerty MB. Carcinoid tumors of the rectum. Am J Surg 1964;107: 844-9.
23. Davis Z, Moertel CG, McIlrath DC. The malignant carcinoid syndrome. Surg Gynecol Obstet 1973;137: 637-42.
24. Feldman JM. Carcinoid tumors and the carcinoid syndrome. Curr Probl Surg 1989;26:835-85.
25. Norheim I, Oberg K, Theodorsson-Norheim E, Lindgren PG, Lundqvist G, Magnusson A et al. Malignant carcinoid tumors. Ann Surg 1987;206:373-8.
26. Kema IP, deVries E, Schellings A, Postmus PE, Muskiet FA. Improved diagnosis of carcinoid tumors by measurement of platelet serotonin. Clin Chem 1992;38: 534-40.
27. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993;104:994-1006.
28. Tormey WP, Fitzgerald RJ. The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid. Postgrad Med 1995;71:542-5.
29. Feldman JM, Lee EM. Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid. Am J Clin Nutr 1985;42:639-43.
30. Kema IP, deVries GE, Sloof MJH, Biesma B, Muskiet FA. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors. Clin Chem 1994;40:86-91.
31. Feldman JM. Urinary serotonin in the diagnosis of carcinoid tumors. Clin Chem 1986;32:840-5.
32. Feldman JM, O'Dorisio TM. The role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med 1986;81:41-8.
33. Davies MG, O'Dowd GO, McEntee GP, Hennessey TP. Primary gastric carcinoid tumors: a view on management. Br J Surg 1990;77:1013-4.
34. Gough DB, Thompson GB, Crotty TB, Donohue JH, Kvols LK, Carney JA. Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World J Surg 1994;18:473-8.
35. Thompson G, van Heerden J, Martin JJ, Schutt AJ, Ilstrup DM, Camey JA. Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery 1985;98:1054-63.
36. Kisker O, Weinel RJ, Geks J, Joseph K, Welcke VH, Zaraca F et al. Value of somatostatin receptor scintigraphy for preoperative localization of carcinoids. World J Surg 1996;20:162-7.
37. Sugimoto E, Lorelius LE, Ericksson B, Oberg K. Midgut carcinoid tumors. Acta Radiol 1995;36:367-74.
38. Dolan JP, Norton JA. Neuroendocrine tumors of the pancreas and gastrointestinal tract and carcinoid disease. In: Gordon TA, Cameron JL editors. Evidencebased surgery. Hamilton, Canada: BC Decker; 2000. p. 919-52.
39. Makridis C, Oberg K, Juhlin C, Rastad J, Johansson H, Lorelius LE et al. Surgical treatment of midgut carcinoid tumors. World J Surg 1990;14:377-83.
40. Cockey BM, Fishman EK, Jones B, Siegelmann SS. Computed tomography of abdominal carcinoid tumor. J Comput Assist Tomogr 1985;9:38-42.
41. Andersson T, Ericksson B, Hemmingson A, Lindgren PG, Oberg K. Angiography, computed tomography, magnetic resonance imaging, and ultrasonography in detection of liver metastases from endocrine gastrointestinal tumors. Acta Radiol 1987;28:535-9.
42. Collatz-Christianson S, Stage JG, Henrikson FW. Angiography in the diagnosis of carcinoid syndrome. Scand J Gastroenterol 1979;1 Suppl 53:11-4.
43. Andersson T, Ericksson B, Lindgren PG, Wilander E, Oberg K. Percutaneous ultrasonography-guided cutting biopsy from liver metastases of endocrine gastrointestinal tumors. Ann Surg 1987;206:728-32.
44. Rioux M, Langis P, Naud F. Sonographic appearance of small bowel carcinoid tumor. Abdom Imaging 1995;20:37-43.
45. Hanson MW, Feldman JM, Blinder RA, Moore JO, Coleman RE. Carcinoid tumors: iodine 131 MIBG scintigraphy. Radiology 1989;172:699-703.
46. Modlin M, Cornelius E, Lawton GP. Use of an isotopic somatostatin probe to image gut endocrine tumors. Arch Surg 1995;130:367-73.
47. Ahlman H, Wangberg B, Tisell LE, Nilssin O, Fjalling M, Forssell-Aronsson E. Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumors and evaluation of intraoperative scintillation detection. Br J Surg 1994;81:1144-9.
48. Meunier B, Le Cloirec J, Dazord L, Leveque J, Lesimple T, Tas P et al. Perioperative localization of a carcinoid tumor of the breast using indium-111 pentreotide and a nuclear surgical probe. Eur J Nucl Med 1995;22: 281-3.
49. Stinner B, Kisker O, Zielke A, Rothmund M. Surgical management of carcinoid tumor of small bowel, appendix, colon, and rectum. World J Surg 1996;20:183-8.
50. Norton JA. Surgical management of carcinoid tumors: role of debulking and surgery in patients with advanced disease. Digestion 1995;55 Suppl 3:98-103.
51. Loftus JP, van Heerden JA. Surgical management of gastrointestinal carcinoid tumors. Adv Surg 1995;28: 317-36.
52. Moertel CG, Dockerty MB, Judd ES. Carcinoid tumors of the vermiform appendix. Cancer 1968;21:270-8.
53. MacGillivray DC, Heaton RB, Rushin JM, Cruess DF. Distant metastases from a carcinoid tumor of the appendix less than 1 cm in size. Surgery 1992;111: 466-71.
54. Gouzi JL, Laigneau P, Delalande JP, Flamant Y, Bloom E, Oberlin P. Indication for right hemicolectomy in carcinoid tumor of the appendix: the French Association for Surgical Research. Surg Gynecol Obstet 1993;176:543-7.
55. Deans GT, Spence RA. Neoplastic lesions of the appendix. Br J Surg 1995;82:299-306.
56. Sauven P, Ridge JE, Quan SH, Sigurdson ER. Anorectal carcinoid tumors: is aggressive surgery warranted? Ann Surg 1990;211:67-71.
57. Federspiel BH, Burke AP, Sokin LH, Shekitka KM. Rectal and colonic carcinoids. Cancer 1990;65:135-9.
58. Koura AN, Giacco GG, Curley SA, Skibber JM, Feig BW, Ellis LM. Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastasis-free survival. Cancer 1997;79:294-8.
59. Burke M, Shepherd N, Mann CV. Carcinoid tumours of the rectum and anus. Br J Surg 1987;74:358-61.
60. Soga J. Carcinoids of the rectum. Acta Med Biol 1982;29:157-201.
61. Sauven P, Ridge J, Quan S, Sigurdson E. Anorectal carcinoid tumors: is aggressive surgery warranted? Ann Surg 1990;211:67-71.
62. Naunheim KS, Zeitels J, Kaplan EL, Sugimoto J, Shen KL, Lee CL. Rectal carcinoid tumors: treatment and prognosis. Surgery 1983;94:670-6.
63. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999;340:858-68.
64. Modlin I, Gilligan CJ, Lawton GP, Tang LH, West AB, Darr U. Gastric carcinoids: the Yale experience. Arch Surg 1995;130:255-6.
65. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 1996;20:168-72.
66. Borch K, Renvall H, Kullman E, Wilander E. Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. Aro J Surg 1987;11:435-44.
67. Hirschowitz BI, Griffith J, Pellegrin D, Cummings OW. Rapid regression of enterocromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 1992;102:1409-18.
68. Eckhauser FE, Lloyd RV, Thompson NW, Raper SE, Vinik SI. Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report. Surgery 1988;104:1046-53.
69. Kirshbom PM, Kherani AR, Onaitis MW, Hata A, Kehoe TE, Feldman C et al. Foregut carcinoids: a clinical and biochemical analysis. Surgery 1999;126:1105-10.
70. Eckhauser FE, Argenta LC, Strodel WE, Wheeler RH, Bull FE, Appelman HD et al. Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids. Surgery 1981;90:720-8.
71. Akerstrom G, Makridis C, Johansson H. Abdominal surgery in patients with midgut carcinoid tumors. Acta Oncol 1991;30:547-53.
72. Dousset B, Saint-Marc O, Pitre J. Metastatic neuroendocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg 1996;20:908-15.
73. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990;108:1091-6.
74. Moertel CG, Johnson CM, McKusick MA, Martin JK, Nagorney DM, Kvols LK et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994;120:302-9.
75. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995;169:36-43.
76. Rothmund M, Kisker O. Surgical treatment of carcinoid tumors of the small bowel, appendix, colon, and rectum. Digestion 1994;55 Suppl 3:86-91.
77. Foster JH, Berman MM. Solid liver tumors. Major Probl Surg 1977;22:1-342.
78. Bechstein WO, Neuhaus P. Liver transplantation for hepatic metastases of neuroendocrine tumors. Ann N Y Acad Sci 1994;733:507-14.
79. Lang H, Oldhafer KJ, Weimann A, Schlitt HJ, Schleumann GF, Flemming P et al. Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 1997;225: 347-54.
80. LeTreut YP, Delpero JR, Dousset B, Cherqui D, Segol P, Mantion G et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors: a 31-case French multicentric report. Ann Surg 1997;225: 355-64.
81. Reichlin S. Somatostatin. N Engl J Med 1983;309: 1495-501.
82. Arnold R, Frank M, Kajdan U. Management of gastroenteropancreatic endocrine tumors: the place of somatostatin analogues. Digestion 1994;55 Suppl 3: 107-13.
83. Schworer H, Munke H, Stockmann F, Ramadori G. Treatment of diarrhea in carcinoid syndrome with ondansetron, tropisetron, and clonidine. Am J Gastroenterol 1995;90:645-8.
84. Robertson JIS. Carcinoid syndrome and serotonin: therapeutic effect of ketanserin. Cardiovasc Drugs Therapy 1990;4:53-6.
85. Gregor M. Therapeutic principles in the management of metastasizing carcinoid tumors: drugs for symptomatic treatment. Digestion 1994;55 Suppl 3:60-3.
86. Ramage JK, Catnach SM, Williams R. Overview: the management of metastatic carcinoid tumors. Liver Transplant Surg 1995;1:107-10.
87. Oberg K, Eriksson B. The role of interferons in the management of carcinoid tumors. Br J Hematol 1991;79 Suppl 1:74-7.
88. Saltz L, Kemeny N, Schwartz G, Kelsen D. A phase-II trial of α-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors. Cancer 1994;74:958-61.
89. Janson ET, Ronnblom L, Ahlstrom H, Grander D, Alm G, Einhorn S. Treatment with alpha interferon versus α interferon in combination with streptozocin and doxorubicin in patients with malignant carcinoid syndrome. Ann Oncol 1992;3:635-8.
90. Maton PN, Hodgson HJF. Carcinoid tumors and the carcinoid syndrome. In: Bouchier IAD, Allan RN, Hodgson HJF, Keighly MRB, editors. Textbook of gastroenterology. London: Balliere-Tindall; 1984.p.620.
91. Kelsen DG, Cheng E, Kemeny N. Streptozotocin and adriamycin in the treatment of APUD tumors (carcinoid, islet cell, and medullary thyroid). Proc Am Assoc Cancer Res 1982;23:433.
92. Moertel CG, Hanley JA. Combination chemotherapy trials in metastatic carcinoid and malignant carcinoid syndrome. Cancer Clin Trials 1979;2:327-30.
93. Idema AA, Tjiong HS, Oldhoff J. Improvements of hepatic dearterialisation: a case report. J Surg Oncol 1980;13:197-205.
94. Ahlman H, Westberg G, Wangberg B, Nilsson O, Tylen U, Schersten T et al. Treatment of liver metastases of carcinoid tumors. World J Surg 1996;20: 196-202.
95. Nobin A, Mansson B, Lunderquist A. Evaluation of temporary liver de-arterialisation and embolization in patients with metastatic carcinoid tumors. Acta Oncol 1989;28:419-24.
96. Mitty HA, Warner RR, Newman LH, Train JS, Parnes IH. Control of carcinoid syndrome with hepatic artery embolization. Radiology 1985;155:623-6.
97. Maton PN, Camillieri M, Griffin G, Allison DJ, Hodgson HJ, Chadwick VS. Role of hepatic artery embolization in the carcinoid syndrome. Br J Med 1983;287: 932-5.
98. Marlink RG, Lakich JJ, Robins JR, Clouse ME. Hepatic arterial embolization for metastatic hormone secreting tumors. Cancer 1991;65:2227-31.
99. Winklebauer FW, Niederle B, Pietschmann F, Thurnher S, Wildling R, Prokesch R et al. Hepatic artery embolization of hepatic metastases from carcinoid tumors: value of using a cranacrylate and ethodized oil. Am J Roentgenol 1995;165:323-7.
100. Stokes KR, Stuart K, Clouse ME. Hepatic artery chemoembolization for metastatic endocrine tumors. J Vasc Interv Radiol 1993;4:341-5.
101. Therasse E, Breittmayer F, Roche A, De Baere T, Indushekar S, Ducreux M et al. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 1993;189:541-7.
102. Zeitels J, Naunheim K, Kaplan E, Il F. Carcinoid tumors: a 37 year experience. Arch Surg 1982;117: 732-7.
103. McDermott E, Guduric B, Brennan M. Prognostic variables in patients with gastrointestinal carcinoid tumors. Br J Surg 1994;81:1007-9.